top of page

Proton Pump Inhibitor

Placeholder Image

Omefil WFI 40mg Powder for Injection

Indication: Used in conditions where inhibition of gastric acid may be beneficial including aspiration syndromes, dyspepsia, gastroesophageal reflux disease, peptic ulcer disease and Zolliger-Ellison syndrome.
FDA REG. NO.: DRP-5025-22

bottom of page